Inventor · disambiguated record
Rong-Hwa Lin
Also filed as: LIN RONG · LIN RONG-HWA
22 granted patents·17 pending applications·268 citations·filing 2002–2024
96Inventor score
Top patents by PatentIndex Score
39 records- 0194US9089614B2Hydrophilic self-immolative linkers and conjugates thereofABGENOMICS INTERNAT INC·Filed 2013·Granted Jul 28, 2015·104 cites·59 claims
- 0294US7674605B2Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using sameBIOALLIANCE CV·Filed 2007·Granted Mar 9, 2010·40 cites·36 claims
- 0392US7604800B2Anti-PSGL-1 antibodiesABGENOMICS COOEPERATIEF U A·Filed 2005·Granted Oct 20, 2009·28 cites·15 claims
- 0490US8361472B2Anti-PSGL-1 antibodiesABGENOMICS COOPERATIEF UA·Filed 2010·Granted Jan 29, 2013·13 cites·4 claims
- 0590US8287871B2Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodiesLIN RONG-HWA·Filed 2009·Granted Oct 16, 2012·11 cites·24 claims
- 0689US8298540B2Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodiesLIN RONG-HWA·Filed 2009·Granted Oct 30, 2012·13 cites·23 claims
- 0786US8663641B2Anti-PSGL-1 antibodiesLIN RONG-HWA·Filed 2012·Granted Mar 4, 2014·6 cites·9 claims
- 0885US8828397B2Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cellLIN RONG-HWA·Filed 2012·Granted Sep 9, 2014·5 cites·16 claims
- 0984US2025092151A1Tetravalent anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2024·Application pending·0 cites
- 1083US7744888B2Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodiesABGENOMICS COOPERATIEF UA·Filed 2002·Granted Jun 29, 2010·19 cites·18 claims
- 1182US9408923B2Hydrophilic self-immolative linkers and conjugates thereofABGENOMICS INT INC·Filed 2015·Granted Aug 9, 2016·5 cites·20 claims
- 1281US9950077B2Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereofBIOALLIANCE CV·Filed 2015·Granted Apr 24, 2018·4 cites·49 claims
- 1381US8557579B2Screening for modulators of PSGL-1 with respect to T cell or NK cell deathLIN RONG-HWA·Filed 2012·Granted Oct 15, 2013·5 cites·9 claims
- 1480US9631019B2Methods of treating GVHD and transplant rejection with anti-PSGL-1 antibodiesABGENOMICS COOP U A·Filed 2014·Granted Apr 25, 2017·3 cites·18 claims
- 1580US8628775B2Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compoundsLIN RONG-HWA·Filed 2009·Granted Jan 14, 2014·5 cites·20 claims
- 1679US10472422B2Tetravalent anti-PSGL-1 antibodies and uses thereofBIOALLIANCE CV·Filed 2017·Granted Nov 12, 2019·1 cites·150 claims
- 1779US9494574B2T-cell death-inducing epitopesLIN RONG-HWA·Filed 2010·Granted Nov 15, 2016·3 cites·8 claims
- 1879US2024084028A1Tetravalent anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2023·Application pending·0 cites
- 1975US10030075B2Methods of treating with anti-PSGL-1 antibodiesABGENOMICS COOP U A·Filed 2017·Granted Jul 24, 2018·1 cites·9 claims
- 2072US9943610B2Hydrophilic self-immolative linkers and conjugates thereofBIOALLIANCE CV·Filed 2013·Granted Apr 17, 2018·1 cites·72 claims
- 2171US9193794B2Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using sameLIN RONG-HWA·Filed 2010·Granted Nov 24, 2015·1 cites·30 claims
- 2271US2022112302A1Tetravalent anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Application pending·0 cites
- 2371US2020277395A1Tetravalent anti-psgl-1 antibodies and uses thereofBIOALLIANCE CV·Filed 2019·Application pending·0 cites
- 2470US2021113710A1Hydrophilic self-immolative linkers and conjugates thereofBIOALLIANCE CV·Filed 2020·Application pending·0 cites
- 2566US10709740B2In vitro pre-conditioned bone marrow-derived mesenchymal stem cells and uses thereofUNIV JOHNS HOPKINS·Filed 2019·Granted Jul 14, 2020·0 cites·20 claims
- 2664US2018238895A1Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using sameBIOALLIANCE CV·Filed 2018·Application pending·0 cites
- 2760US10478458B2In vitro pre-conditioned bone marrow-derived mesenchymal stem cells and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Nov 19, 2019·0 cites·20 claims
- 2860US2018264131A1Hydrophilic self-immolative linkers and conjugates thereofBIOALLIANCE CV·Filed 2018·Application pending·0 cites
- 2959US2016139131A1Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using sameBIOALLIANCE CV·Filed 2015·Application pending·0 cites
- 3055US2014065176A1T-cell death-inducing epitopesABGENOMICS COOPERATIEF UA·Filed 2013·Application pending·0 cites
- 3155US2009124688A1Prostaglandin reductase inhibitorsLIN RONG-HWA·Filed 2007·Application pending·0 cites
- 3254US2006003940A1T-cell death-inducing epitopesLIN RONG-HWA·Filed 2005·Application pending·0 cites
- 3351US2004116333A1Modulators of P-selectin glycoprotein ligand 1Filed 2003·Application pending·0 cites
- 3446US2006040876A1Modulation of peroxisome proliferator-activated receptorsLIN RONG-HWA·Filed 2005·Application pending·0 cites
- 3545US2003049694A1Production of fusion proteins and use for identifying binding moleculesFiled 2002·Application pending·0 cites
- 3639US6800462B2Production of recombinant proteins in vivo and use for generating antibodiesABGENOMICS CORP·Filed 2002·Granted Oct 5, 2004·0 cites·38 claims
- 3737US2016051695A1Her2 antibody-drug conjugatesABGENOMICS INTERNAT INC·Filed 2015·Application pending·0 cites
- 3836US2007037193A1Modulation of peroxisome proliferator-activated receptorsLIN RONG-HWA·Filed 2006·Application pending·0 cites
- 3933US2016015831A1Anti-cd22 antibody-drug conjugates and methods of using thereofBIOALLIANCE CV·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →